The effect of insulin-like growth factor II in the regulation of tumour cell growth in vitro and tumourigenesis in vivo

In Vivo

Volumn 26, Issue 4, 2012, Pages 519-526

  Halje, Matilda ^a   Nordin, Matilda ^a   Bergman, Daniel ^a   Engström, Wilhelm ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

IGF II; In vitro; In vivo; Review; Tumour; Tumourigenesis

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RELAXIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

AMINO TERMINAL SEQUENCE; APOPTOSIS; AUTOCRINE EFFECT; AUTOPHOSPHORYLATION; BINDING AFFINITY; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CARCINOMA; DNA SYNTHESIS; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LEYDIG CELL TUMOR; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NEPHROBLASTOMA; NONHUMAN; PARACRINE SIGNALING; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SEMINOMA; TERATOCARCINOMA; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; CELL DIVISION; CELL TRANSFORMATION; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; NEOPLASMS;

EID: 84865093110     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Rinderknecht E and Humbel RE: Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: Evidence for structural homology with insulin B chain. Proc Natl Acad Sci USA 73 : 4379-4381, 1976. (Pubitemid 8013979)
2. Rinderknecht E and Humbel RE.: Primary structure of insulinlike growth factor II. FEBS Lett 89: 283-286, 1978. (Pubitemid 8340912)
3. Engström W, Shokrai A, Otte K, Granerus M, Gessbo Å, Bierke P, Madej A, Sjölund M and Ward A: Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prolif 31 : 173-189, 1998.
4. DeChiara TM, Robertson EJ and Efstratiadis A: A growth deficiency phenotype in heterozygous mice carrying an insulinlike growth factor II gene disrupted by targeting. Nature 34 : 78- 80, 1990.
5. De Chiara TM, Robertson EJ, and Efstratiadis A: Parental imprinting of the mouse insulin like growth factor II gene. Cell 64: 849-859, 1991. (Pubitemid 121001171)
6. Ward A, Bierke P, Pettersson E and Engström W: Insulin like growth factors; Genes, transgenes and imprinting. Zool Sci 11: 167-174 1994.
7. Chao W and D'Amore PA: IGF2: Epigenetic regulation and role in development and disease. Cytokine Growth Factor Rev 19: 111-120, 2008. (Pubitemid 351382280)
8. Hossner KL, McCusker RH and Dodson MV: Insulin-like growth factors and their binding proteins in domestic animals. Animal Sci 64: 1-15, 1997. (Pubitemid 127469401)
9. Belfiore A, Frasca F, Pandini G, Sciacca L and Vigneri R: Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Rev 30: 586-623, 2009.
10. Causin C, Waheed A, Braulke T, Junghans U, Maly P, Humbel, RE. and Von Figura K: Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor. Biochem J 252 : 795-799, 1988.
11. Grimme S, Höning S, Von Figura K. and Schmidt, B: Endocytosis of Insulin-like Growth Factor II by a Mini-receptor Based on Repeat 11 of the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor. J Biol Chem 275 : 33697-33703, 2000.
12. Bassim Hassan A: Keys to the hidden treasures of the mannose 6-phosphate/insulin-like growth factor 2 receptor. Am J Path 162: 3-6, 2003.
13. Zaina S, Newton RVS, Paul MR and Graham, CF: Local Reduction of Organ Size in Transgenic Mice Expressing a Soluble Insulin-Like Growth Factor II/Mannose-6-Phosphate Receptor. Endocrinology 139: 3886-3895, 1998. (Pubitemid 28512272)
14. Prince SN, Foulstone EJ, Zaccheo OJ, Williams C and Bassim Hassan A: Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor. Mol Cancer Therap 6: 607-617, 2007. (Pubitemid 46332463)
15. Kim H, Nagalla SR, Oh Y, Wilson E and Roberts CT Jr.: Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. J Cell Biol 94: 12981-12986, 1997. (Pubitemid 27518462)
16. Hwa V, Oh Y. and Rosenfeld RG: The Insulin-Like Growth Factor-Binding Protein Superfamily. Endocrine Rev 20: 761-787, 1999. (Pubitemid 30648894)
17. Otte K. The equine IGF genes. Structural and transcriptional features. Acta Univ Agricult Sueciae Veterinaria 24: 9-54, 1997.
18. Scharf JG, Dombrowski F and Ramadori, G: The IGF axis and hepatocarcinogenesis. J of Clin Path 54: 138-144, 2001. (Pubitemid 32539603)
19. Gao Y, Katki H, Graubard B, Pollack,M, Martin M, Tao Y, Schoen RE, Church T, Hayes, RB., Greene MH and Berndt SI: Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. Int J Cancer 131: E105-E113, 2012.
20. Kull FC, Jacobs, Su, YF, Svoboda ME, Van Wyk JJ and Cuatrecasas P: Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem 258: 6561-6566, 1983.
21. Thompson S, Stern PL, Webb M, Walsh FS, Engström W, Evans EP, Shi WK, Hopkins B and Graham CF: Cloned human teratoma cells differentiate into neuron like cells and other cell types in retinoic acid. J Cell Sci 72: 37-64, 1984. (Pubitemid 15129396)
22. Engström W, Rees AR and Heath JK: Proliferation of a human embryonal carcinoma-derived cell line in serum-free medium: Inter-relationship between growth factor requirements and membrane receptor expression. J Cell Sci 73 : 361-373, 1985.
23. Granerus M, Bierke P, Zumkeller W, Smith J, Engström W and Schofield PN: Insulin-like growth factor II prevents apoptosis in a human teratoma-derived cell line. J Clin Path 48 : 153-157, 1995.
24. Reeve AE, Eccles M, Wilkins RJ, Bell GI and Millow LJ: Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317 : 258-260, 1985. (Pubitemid 16246502)
25. Scott J, Cowell J, Roberttson ME, Priestly LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF and Knott TJ: Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature 317: 260-262, 1985. (Pubitemid 16246503)
26. Granérus M, Johannisson A, Ekblom P and Engström W: Insulin-like growth factors I and II induce cell death in Wilms tumour cells. J Clin Path 54: 30-35, 2001.
27. Osborne K, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SAW, Ramasharma K, Marshall M and Li CH: Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrin 3: 1701-1709, 1989. (Pubitemid 20003652)
28. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Scalia P, Sbraccia P, Goldfine ID, Vigner R and Belfiore A: Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 18: 2471-2479, 1999. (Pubitemid 29206160)
29. Kalla Singh S, Tan OW, Brito C, de Leon M, Garberoglio C and de Leon D: Differential insulin like growth factor II expression. A potential role for breast cancer survival disparity. Growth Horm IGF Res 20: 162-70, 2010.
30. Havemann K, Rotsch M, Schöneberger H-J, Erbil C, Henning C and Jaques G: Growth regulation of insulin-like growth factors in lung cancer. J Ster Biochem Mol Biol 37: 877-882, 1990.
31. Kaiser U, Schardt C, Brandscheidt D, Wollmer E and Havemann K: Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer. J Cancer Res Clin Oncol 119: 665-668, 1993. (Pubitemid 23238149)
32. Zhan S, Shapiro D, Zhan S, Zhang L, Hirschfeld S, Elassal J and Helman LJ: Concordant Loss of Imprinting of the Human Insulin-like Growth Factor II Gene Promoters in Cancer. J Biol Chem 270: 27983-27986, 1995.
33. Quinn A, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine, JL and Cuttitta F:Insulin-like Growth Factor Expression in Human Cancer Cell Lines. J Biol Chem 271 : 11477-11483, 1996. (Pubitemid 26155990)
34. Nussbaum T, Samarin J, Ehemann V, Ryschich E, Khamidjanov A, Yu X, Gretz N, Schirmacher P and Breuhahn K: Autocrine insulin like growth factor II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. Hepatology 48: 146-156, 2008. (Pubitemid 351975539)
35. Nussbaum T, Samarin J, Schirmacher P and Breuhahn K: Insulin like growth factor signaling pathway components are potential therapeutic targets in the treatment of human hepatocellular carcinoma. Verh Deutsch Ges Pathol 91 : 278-285, 2007.
36. Nussbaum T, Vreden S, Farsad M, Schirmacher P and Breuhahn K: Insulin-like growth factor II in human hepatogenesis - a potential therapeutic target. Verh Deutsch Ges Pathol 89 : 254- 260, 2005.
37. Tomizawa M and Saisho H: Insulin like growth factor II regulates CCAAT/enhancer binding protein alpha expression via phosphoinositol 3 kinase in human hepatoblastoma cell lines. J Cell Biochem 102 : 161-170, 2007. (Pubitemid 47378919)
38. Lahm H, Amstad P, Wyniger J, Yilmaz A, Fischer JR, Schreyer M and Givel JC: Blockade of the insulin-like growth factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop. Int J Cancer 58 : 452-459, 1994. (Pubitemid 24254660)
39. Lim DY, Cho HJ, Kim J, Nho CW, Lee KW and Park JHY: 1,2- Luteolin decreases IGF-II production and down-regulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. BMC Gastroenterol 12 : 9, 2012.
40. Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P and Barany F: Loss of imprinting and marked gene elevation are two forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer 127 : 568-577, 2010.
41. Engström W, Hopkins B and Schofield P: Expression of growth regulatory genes in primary human testicular neoplasms. Int J Androl, 10: 79-84, 1987.
42. Haselbacher GK, Irminger JC, Zapf J, Ziegler WH and Humbel RE: Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms' tumors: Expression at the mRNA and protein level. Proc Natl Acad Sci, USA 84: 1104-1106, 1987. (Pubitemid 17031577)
43. Baccarini P, Fiorentino M, D'Errico A, Mancini A and Grigioni WF: Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor. Am J Pathol 14: 1535-1542, 1993. (Pubitemid 24058256)
44. Duarte A, Caricasole A, Graham CF and Ward A: Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype. Br J Cancer 77 : 253-259, 1998. (Pubitemid 28029542)
45. Christofori G, Naik P and Hanahan P: A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369 : 414-418, 1994.
46. Bates P, Fisher R, Ward A, Richardson L, Hill DJ and Graham, CF: Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72: 1189-1193, 1995.
47. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K and Hintz R: Altered Body Composition and Increased Frequency of Diverse Malignancies in Insulin-like Growth Factor-II Transgenic Mice. J Biol Chem 269 : 13779- 13784, 1994.
48. Richardson AE, Hamilton N, Davis W, Brito C, de Leon D. Insulin like growth factor 2 activates estrogen receptor alpha and beta via the IGF-1 and the insulin receptors in breast cancer cells. Growth Factors 29: 82-93, 2011.
49. Alexia C, Fallot G, Lafer M, Schweizer-Groyer G and Grover A: An evaluation of the role of insulin-like growth factors and of type I receptor signaling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 68 : 1003-1015, 2004. (Pubitemid 39094263)
50. Hochscheid R, Jaques G and Wegmann B: Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: A cell culture model for lung cancer. J Endocrinol 166: 553-563, 2000.
51. Moorehead RA, Sanchez OH, Baldwin RM and Khokha R: Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma. Oncogene 22: 853-857, 2003. (Pubitemid 36255821)
52. Wu K, Feskanich D, Fuchs CS, Chan AT, Willett WC, Hollis BW, Pollak MN and Giovannucci E: Interactions between plasma levels of 25-hydroxyvitamin D, insulin like growth factor I and C-peptide with risk of colon cancer. PLoS One 6: e28520, 2011.
53. Salmon WD and Daughaday WH: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49(6): 825-836, 1957.
54. Engström W, Ward A and Moorwood K: The role of scaffold proteins in JNK signaling. Cell Prolif 43: 56-66, 2010.
55. Engström W and Granerus M: Expression of JNK-interacting protein JIP-1 and insulin-like growth factor II in Wilms' tumour cell lines and primary Wilms' tumours. Anticancer Res 29: 2467- 2472, 2009.
56. Perks CM, Vernon EG, Rosendahl AH, Tonge D and Holly, JMP: IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene 26 : 5966-5972, 2007.